Semler Scientific(SMLR)
Search documents
Semler Scientific(SMLR) - 2023 Q2 - Earnings Call Transcript
2023-08-11 03:36
Start Time: 16:30 January 1, 0000 4:49 PM ET Semler Scientific, Inc. (NASDAQ:SMLR) Q2 2023 Earnings Conference Call August 10, 2023, 16:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO Renae Cormier - CFO Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Good afternoon, and welcome to the Semler Scientific 2023 Second Quarter Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. After today’s presentation, there ...
Semler Scientific(SMLR) - 2023 Q1 - Quarterly Report
2023-05-12 20:15
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___ to ___ Commission File Number 001-36305 SEMLER SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 26-1367393 (State o ...
Semler Scientific(SMLR) - 2023 Q1 - Earnings Call Transcript
2023-05-11 00:44
Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Douglas Murphy-Chutorian - Interim Chief Executive Officer Renae Cormier - Head of Corporate Communications and Business Strategy Andrew Weinstein - Senior Vice President, Finance and Accounting Dennis Rosenberg - Chief Marketing Officer Conference Call Participants Operator Good afternoon, and welcome to the Semler Scientific 2023 First Quarter Financial Results Conference Call. All participa ...
Semler Scientific(SMLR) - 2022 Q4 - Annual Report
2023-03-23 21:01
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to Commission file number: 001-36305 SEMLER SCIENTIFIC, INC. (Exact name of registrant as specified in its charter) Delaware 26-1367393 (State or other ju ...
Semler Scientific(SMLR) - 2022 Q4 - Earnings Call Transcript
2023-03-21 23:27
Semler Scientific, Inc. (NASDAQ:SMLR) Q4 2022 Results Conference Call March 21, 2023 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Wayne Pan - New CEO Renae Cormier - Head, Corporate Communication and Business Strategy Andrew Weinstein - SVP, Finance & Accounting Dennis Rosenberg - Chief Marketing Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Good afternoon, and welcome to the Semler Scientific 2022 Fourth Quarter and Full Yea ...
Semler Scientific(SMLR) - 2022 Q3 - Earnings Call Transcript
2022-11-02 00:39
Semler Scientific, Inc. (NASDAQ:SMLR) Q3 2022 Earnings Conference Call November 1, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary Dennis Rosenberg - Chief Marketing Officer Renae Cormier - Head, Corporate Communication and Business Strategy Andrew Weinstein - SVP, Finance & Accounting Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Marc Wiesenberger - B. Riley Securities Operator Hello and welcome to the Semler Scientific Third Quarter 2022 ...
Semler Scientific(SMLR) - 2022 Q2 - Earnings Call Presentation
2022-08-03 02:00
NASDAQ:SMLR August 2022 Forward-Looking Statements This presentation includes statements that are, or may be deemed, "forward-looking statements." In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believe," "estimate," "anticipate," "expect," "plan," "intend," "may," "could," "might," "will," "should," or, in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking stateme ...
Semler Scientific(SMLR) - 2022 Q2 - Earnings Call Transcript
2022-08-03 01:41
Semler Scientific, Inc. (NASDAQ:SMLR) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary & Director Renae Cormier - Head, Corporate Communication and Business Strategy Andrew Weinstein - SVP, Finance & Accounting Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Marc Wiesenberger - B. Riley Securities Operator Good afternoon, and welcome to the Semler Scientific Second Quarter 2022 Financial Results Confe ...
Semler Scientific(SMLR) - 2022 Q1 - Earnings Call Transcript
2022-05-03 00:54
Semler Scientific, Inc. (NASDAQ:SMLR) Q1 2022 Earnings Conference Call May 2, 2022 10:30 AM ET Company Participants Douglas Murphy-Chutorian - CEO Dennis Rosenberg - Chief Marketing Officer Andrew Weinstein - SVP, Finance and Accounting Conference Call Participants Brooks O’Neil - Lake Street Capital Markets LLC Marc Wiesenberger - B. Riley Securities, Inc. Operator Good day, and welcome to the Semler Scientific First Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mo ...
Semler Scientific (SMLR) Investor Presentation -Slideshow
2022-04-14 16:24
NASDAQ:SMLR March 2022 Forward-Looking Statements This presentation includes statements that are, or may be deemed, "forward-looking statements." In some cases, these forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believe," "estimate," "anticipate," "expect," "plan," "intend," "may," "could," "might," "will," "should," or, in each case, their negative or other variations thereon or comparable terminology, although not all forward-looking statemen ...